Your World, Fully Explored.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Leo XIV
Mother's Day
Pope Francis
Baseball
Catholic Church
Military
Social Media
Donald Trump
Cricket
Natural Disasters
Vladimir Putin
Property
Published • loading... • Updated

Sen. Sanders pushes NIH to rein in drug prices

Summary by Ground News
National Institutes of Health doesn't approve new medicines or pay for them. But its role in drug research gives it surprising leverage. Sen. Bernie Sanders voted against Dr. Monica Bertagnolli as NIH director. He says something has to change at the NIH, which spends billions on biomedical research.

1 Articles

All
Left
1
Center
Right
nprnpr
Lean Left

Sen. Sanders pushes NIH to rein in drug prices

The National Institutes of Health has been reluctant to use its leverage as a biomedical research funder to influence drug pricing. Sen. Bernie Sanders is pressing NIH's new director to take action.(Image credit: Kevin Dietsch/Getty Images)

·Washington, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

npr broke the news in Washington, United States on Friday, November 17, 2023.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Drug Prices

Drug Prices

National Institutes of Health

National Institutes of Health

News
For You
SearchBlindspotLocal